Advances in Lung Transplantation - Royal Perth Hospital
Advances in Lung Transplantation - Royal Perth Hospital
Advances in Lung Transplantation - Royal Perth Hospital
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
hange <strong>in</strong> FEV1 (% pred) after switch from CyA to Tacrolimus<br />
FEV1% predicted<br />
90<br />
80<br />
70<br />
60<br />
50<br />
40<br />
30<br />
20<br />
10<br />
0<br />
FEV1( % pred) - Time course<br />
Mean monthly loss <strong>in</strong><br />
FEV1% = 2.65%<br />
Best value 6 mo. 3 mo. switch 3 mo. 6 mo. 12 mo.<br />
OB RAR Total<br />
Mean monthly loss <strong>in</strong><br />
FEV1% = 1.0%<br />
arahrudi K, Estenne M, Corris P, Niedermayer J, Knoop C, Glanville AR, Chapparo C et al.<br />
nternational experience with conversion from cyclospor<strong>in</strong>e to tacrolimus for acute and chronic lung allograft rejection.<br />
Thorac Cardiovasc Surg, 2004; 127:1126-1132.
Change language